Security Snapshot

COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) Institutional Ownership

CUSIP: M25722105

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

68

Shares (Excl. Options)

12,593,325

Price

$1.53

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Ordinary Shares, par value NIS 0.01
Symbol
CGEN on Nasdaq
Shares outstanding
89,326,990
Price per share
$2.58
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
12,593,325
Total reported value
$19,268,128
% of total 13F portfolios
0%
Share change
-893,711
Value change
-$1,280,211
Number of holders
68
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CGEN - COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 is tracked under CUSIP M25722105.
  • 68 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 68 to 23 between Q4 2025 and Q1 2026.
  • Reported value moved from $19,268,128 to $4,433,700.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 68 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP M25722105?
CUSIP M25722105 identifies CGEN - COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BRISTOL MYERS SQUIBB CO 2.1% $2,723,401 1,840,136 BRISTOL MYERS SQUIBB CO 31 Dec 2024

As of 31 Dec 2025, 68 institutional investors reported holding 12,593,325 shares of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN). This represents 14% of the company’s total 89,326,990 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) together control 13% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SILVERARC CAPITAL MANAGEMENT, LLC 3.9% 3,479,805 +5.1% 0.77% $5,324,102
RENAISSANCE TECHNOLOGIES LLC 1.6% 1,456,900 +3.7% 0% $2,229,057
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.1% 1,020,000 0% 0% $1,561,000
MORGAN STANLEY 1.1% 1,009,701 -4.7% 0% $1,544,843
Taylor Frigon Capital Management LLC 0.97% 869,227 -9.9% 0.67% $1,329,917
NORTHERN TRUST CORP 0.74% 658,906 0% 0% $1,008,126
STATE STREET CORP 0.44% 393,802 +3.9% 0% $602,517
UBS Group AG 0.39% 350,461 +18% 0% $536,205
Yelin Lapidot Holdings Management Ltd. 0.36% 318,852 0% 0.1% $487,844
Stonepine Capital Management, LLC 0.34% 305,400 0.37% $467,262
TWO SIGMA INVESTMENTS, LP 0.34% 303,943 +54% 0% $465,033
DAFNA Capital Management LLC 0.3% 272,402 0% 0.1% $416,775
TWO SIGMA ADVISERS, LP 0.28% 248,884 -3.5% 0% $380,793
CITADEL ADVISORS LLC 0.18% 157,115 -15% 0% $240,386
ROTHSCHILD INVESTMENT LLC 0.16% 143,600 -19% 0.01% $219,708
MARSHALL WACE, LLP 0.12% 106,304 +136% 0% $162,645
Atom Investors LP 0.12% 104,396 -68% 0.01% $159,726
RAYMOND JAMES FINANCIAL INC 0.12% 103,856 +2.6% 0% $158,899
MATRIX ASSET ADVISORS INC/NY 0.11% 93,833 0% 0.01% $143,564
SCHNIEDERS CAPITAL MANAGEMENT, LLC. 0.1% 90,000 0% 0.02% $137,700
Kingsview Wealth Management, LLC 0.09% 83,179 0% 0% $127,264
JANE STREET GROUP, LLC 0.08% 74,300 -32% 0% $113,680
GOLDMAN SACHS GROUP INC 0.08% 72,008 -0.41% 0% $110,172
EAGLE ROCK INVESTMENT COMPANY, LLC 0.08% 71,212 0% 0.02% $108,954
XTX Topco Ltd 0.08% 67,903 0% $103,892

Institutional Holders of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,081,448 $4,433,700 -$74,639 $2.13 23
2025 Q4 12,593,325 $19,268,128 -$1,280,211 $1.53 68
2025 Q3 12,448,286 $18,304,014 -$4,183,367 $1.47 67
2025 Q2 15,139,685 $26,790,623 +$183,382 $1.78 68
2025 Q1 15,090,164 $22,053,607 +$4,245,948 $1.46 71
2024 Q4 12,186,219 $18,646,397 -$28,651 $1.53 68
2024 Q3 11,987,352 $21,696,784 -$567,864 $1.81 64
2024 Q2 12,305,636 $20,720,522 -$1,505,161 $1.68 65
2024 Q1 12,748,693 $32,862,738 +$5,173,490 $2.58 71
2023 Q4 10,826,281 $21,446,061 -$868,253 $1.98 71
2023 Q3 12,534,496 $11,648,799 +$912,972 $0.93 61
2023 Q2 11,454,619 $13,055,912 +$792,401 $1.14 63
2023 Q1 10,938,583 $7,680,803 -$3,735,798 $0.70 64
2022 Q4 16,116,742 $11,522,279 -$3,810,001 $0.72 66
2022 Q3 21,939,171 $14,470,393 -$27,601,323 $0.66 71
2022 Q2 38,292,142 $70,071,925 -$7,799,772 $1.85 81
2022 Q1 41,974,425 $135,261,109 +$24,332,823 $3.22 103
2021 Q4 34,045,006 $147,109,241 -$8,267,484 $4.30 110
2021 Q3 35,282,290 $210,636,141 -$11,592,998 $5.97 103
2021 Q2 36,945,470 $305,730,622 -$26,358,920 $8.28 105
2021 Q1 40,064,043 $344,003,423 +$10,868,134 $8.59 105
2020 Q4 38,405,443 $465,291,847 -$89,128,926 $12.11 99
2020 Q3 43,347,749 $704,457,313 +$67,071,360 $16.25 107
2020 Q2 39,307,332 $590,159,903 +$135,675,063 $15.02 90
2020 Q1 31,865,087 $231,287,000 +$63,846,487 $7.26 65
2019 Q4 23,097,585 $137,648,000 +$8,576,336 $5.96 54
2019 Q3 21,656,187 $91,586,000 +$26,415,199 $4.23 42
2019 Q2 15,375,371 $59,066,000 +$5,570,229 $3.84 41
2019 Q1 13,973,276 $57,854,000 +$9,460,253 $4.14 39
2018 Q4 11,728,077 $25,448,000 +$522,008 $2.17 36
2018 Q3 11,120,308 $42,813,000 +$2,424,453 $3.85 34
2018 Q2 10,631,974 $35,083,000 -$4,178,184 $3.30 35
2018 Q1 10,870,849 $48,282,000 +$3,972,904 $4.45 36
2017 Q4 10,576,715 $26,442,000 +$3,741,499 $2.50 37
2017 Q3 8,913,963 $33,869,000 -$2,319,225 $3.80 34
2017 Q2 8,943,614 $33,994,000 -$1,142,087 $3.80 36
2017 Q1 9,200,354 $39,559,000 +$3,929,235 $4.30 39
2016 Q4 8,937,685 $45,579,425 +$227,680 $5.10 49
2016 Q3 8,658,716 $54,510,000 +$9,580,174 $6.30 46
2016 Q2 7,123,813 $46,158,000 +$4,710,745 $6.48 41
2016 Q1 6,412,273 $35,778,820 +$1,301,148 $5.58 41
2015 Q4 6,163,378 $39,350,000 +$10,613,523 $6.39 49
2015 Q3 4,502,769 $23,270,760 -$1,241,474 $5.17 41
2015 Q2 4,469,489 $31,003,246 -$1,063,840 $6.94 43
2015 Q1 4,083,380 $32,603,303 +$1,085,507 $7.05 42
2014 Q4 3,439,266 $36,782,604 -$13,047,015 $8.33 39
2014 Q3 2,857,139 $52,681,832 +$30,108,934 $8.57 37
2014 Q2 2,631,385 $23,650,509 -$11,356,232 $8.99 34
2014 Q1 3,729,722 $39,199,863 +$6,976,688 $10.51 42
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .